Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.63 USD | +0.13% | +0.25% | +8.66% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.